TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
8.96
+0.16 (1.82%)
Oct 16, 2026, 1:30 PM CST
| Market Cap | 6.38B +6.2% |
| Revenue (ttm) | 256.46M +530.4% |
| Net Income | 155.12M |
| EPS | 0.21 |
| Shares Out | 711.83M |
| PE Ratio | 42.33 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,421,465 |
| Open | 8.87 |
| Previous Close | 8.80 |
| Day's Range | 8.85 - 9.17 |
| 52-Week Range | 7.73 - 16.40 |
| Beta | 0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |